Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Oaktree Capital Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Oaktree Capital Management
from 13F filings
Historical chart of Oaktree Capital Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Oaktree Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $976k | 750k | 1.30 |
| 2025-03-31 | $1.2M | 1.0M | 1.15 |
| 2024-12-31 | $1.4M | 1.4M | 1.07 |
| 2024-09-30 | $2.1M | 1.8M | 1.17 |
| 2024-03-31 | $2.8M | 2.9M | 0.94 |
| 2023-12-31 | $2.5M | 2.5M | 0.99 |
| 2023-09-30 | $2.3M | 2.5M | 0.93 |
More positions owned by Oaktree Capital Management
View all positions for Oaktree Capital Management
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1